Literature DB >> 28178115

Prevalence of and Risk Factors for Oral Human Papillomavirus Infection With Multiple Genotypes in the United States.

Thanh Cong Bui1, Ly Thi-Hai Tran, Thuy Nhu Thai, Sanjay S Shete, Damon J Vidrine, Erich M Sturgis.   

Abstract

BACKGROUND: This study investigated the prevalence of and risk factors for oral human papillomavirus (HPV) infection with multiple genotypes in the United States.
METHODS: Data were from the nationally representative 2009-2012 National Health and Nutrition Examination Survey. This analysis comprised 9257 participants for whom data on oral HPV (37 genotypes) and associated risk factors were available.
RESULTS: The weighted prevalence of multitype (2-6 types) oral HPV infection was 1.5% (2.5% for men, 0.4% for women) in the whole sample and 19.7% (22.0% for men, 12.1% for women) in those who had any type of oral HPV positivity. Most multitype oral HPV cases (83.8%) harbored one or more oncogenic types. In the adjusted multinominal logistic regression model, being male (relative risk ratio [RRR] = 3.69; 95% confidence interval [CI], 1.57-8.65), being a current cigarette smoker (RRR = 2.57; 95% CI, 1.23-5.36), and having a new sex partner in the past year (RRR = 2.10; 95% CI, 1.03-4.28) were associated with an increased risk of multitype oral HPV infection over single-type HPV infection.
CONCLUSIONS: Men, smokers, and those who had new sexual partners were at a significantly higher risk for multitype oral HPV infection.

Entities:  

Mesh:

Year:  2017        PMID: 28178115      PMCID: PMC6710830          DOI: 10.1097/OLQ.0000000000000563

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  29 in total

Review 1.  Cigarette smoking and innate immunity.

Authors:  H Mehta; K Nazzal; R T Sadikot
Journal:  Inflamm Res       Date:  2008-11       Impact factor: 4.575

2.  Human papillomavirus infections with multiple types and risk of cervical neoplasia.

Authors:  Helen Trottier; Salaheddin Mahmud; Maria Cecilia Costa; João P Sobrinho; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

3.  Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.

Authors:  Fabian Mendez; Nubia Munoz; Hector Posso; Monica Molano; Victor Moreno; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Munoz
Journal:  J Infect Dis       Date:  2005-08-29       Impact factor: 5.226

4.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

Review 5.  Oral human papillomavirus in healthy individuals: a systematic review of the literature.

Authors:  Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-06       Impact factor: 2.830

6.  Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

Authors:  Raphael P Viscidi; Mark Schiffman; Allan Hildesheim; Rolando Herrero; Philip E Castle; Maria C Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Sophia Wang; Barbara Clayman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-02       Impact factor: 4.254

7.  Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response.

Authors:  Radha Munagala; M Gabriella Donà; Shesh N Rai; Alferd B Jenson; Nagarajan Bala; Shin J Ghim; Ramesh C Gupta
Journal:  Int J Oncol       Date:  2009-01       Impact factor: 5.650

8.  Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Rolando Herrero; Nubia Muñoz; Peter J F Snijders; Gary M Clifford; Jennifer S Smith; Eduardo Lazcano-Ponce; Sukhon Sukvirach; Hai-Rim Shin; Silvia de Sanjosé; Monica Molano; Elena Matos; Catterina Ferreccio; Pham Thi Hoang Anh; Jaiye O Thomas; Chris J L M Meijer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

9.  Oral sexual behaviors associated with prevalent oral human papillomavirus infection.

Authors:  Gypsyamber D'Souza; Yuri Agrawal; Jane Halpern; Sacared Bodison; Maura L Gillison
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

Review 10.  Effects of tobacco smoke on immunity, inflammation and autoimmunity.

Authors:  Yoav Arnson; Yehuda Shoenfeld; Howard Amital
Journal:  J Autoimmun       Date:  2009-12-29       Impact factor: 7.094

View more
  2 in total

1.  Detection of Oral Human Papillomavirus (HPV) and its Clinical Importance.

Authors:  Gabriela Nalli; Paula Mastrotta; María Gabriela Garcia; Silvio Tatti; Sergio Verdú
Journal:  J Dent (Shiraz)       Date:  2022-03

2.  Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study.

Authors:  S-J Perdomo-Lara; M-R Buenahora; E Álvarez; F González-Martínez; M Rebolledo; F-A Aristizabal; C-H Colegial; A Horta; J Bustillo; D Díaz-Báez; C-M Ardila; G-I Lafaurie
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.